Laguna Tech USA Announces Site Record Number of Transcatheter Heart Valves Implanted at Single Center on Same Day in First-in-Human Clinical Trial
RVINE, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) — Laguna Tech USA, a privately-held medical technology company dedicated to innovations in structural heart solutions to broaden useability and applicability for patients, today announced that a record number five patients were successfully treated at a single center on the same day with the ZETA Balloon Expandable Aortic […]
Laguna Tech USA Announces Newly Designed Heart Valves with Advanced Engineering Successfully Implanted in First-in-Human Clinical Trial
IRVINE, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) — Laguna Tech USA, a privately-held medical technology company dedicated to innovations in structural heart solutions to broaden useability and applicability for patients, today announced that the first-in-human clinical case was completed with the Zeta Balloon Expandable Aortic Valve System and additional patients have been successfully treated in […]
Laguna Tech USA Begins FIH Trial of Alpha TAVR System
June 21, 2023—Laguna Tech USA announced that the first patient has been treated in the first-in-human clinical trial of the company’s investigational Alpha transcatheter aortic valve replacement (TAVR) system to treat aortic regurgitation. Laguna Tech is a privately-held medical technology company with headquarters in Irvine, California. According to the company, the Alpha TAVR system is […]
Laguna Tech USA announces Patent
Laguna Tech USA announces Patent Granted by USPTO (US 11,806,233), Strengthening the Company’s Intellectual Property Position in the crowded TAVR Market For more information contact Laguna Tech USA at info@lagunatechmed.com